However, seven BRCA1 and six BRCA2 germline truncations (MAF≤0.05%) were detected in other cancer types (three each in endometrial, stomach and lung cancers, two in kidney cancer and one each in prostate and head and neck cancers). This evidence concerns the gene BRCA1 and kidney cancer.